Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cell factor: laboratory and clinical aspects.

M A Smith1, E L Court, J G Smith

  • 1Centre for Research in Biomedicine, Faculty of Applied Sciences, University of the West of England, Bristol, UK.

Blood Reviews
|January 17, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

National Comparative Audit of Blood Transfusion: report on the 2014 audit of patient information and consent.

Transfusion medicine (Oxford, England)·2017
Same author

Observation of the decay B- → D(s)((*)+) K- ℓ- ν(ℓ).

Physical review letters·2011
Same author

A retrospective wound review of standard four-port laparoscopic cholecystectomy: is there need for single-port laparoscopic surgery?

Surgical endoscopy·2011
Same author

Measurement of the polarization of W bosons with large transverse momenta in W + jets events at the LHC.

Physical review letters·2011
Same author

Search for production of invisible final states in single-photon decays of Υ(1S).

Physical review letters·2011
Same author

Search for neutral minimal supersymmetric standard model Higgs bosons decaying to tau pairs in pp collisions at √s=7 TeV.

Physical review letters·2011
Same journal

Treating large B-cell lymphoma: Current strategies and unmet needs across community and academic settings.

Blood reviews·2026
Same journal

MRD in multiple myeloma: Moving from "minimal" to "measurable".

Blood reviews·2026
Same journal

PRISMA-based systematic review on iron stores in repeat blood donors.

Blood reviews·2026
Same journal

Artificial intelligence applications in thrombotic thrombocytopenic Purpura: A systematic review of diagnostic, risk stratification, and prognostic models.

Blood reviews·2026
Same journal

Antibacterial, antifungal and antiviral prophylaxis and vaccination strategies in adult patients with acute myeloid and promyelocytic leukemia: An expert panel consensus from the GIMEMA group.

Blood reviews·2026
Same journal

The Lebanese national patient blood management guidelines: A new page in the medical practice.

Blood reviews·2026
See all related articles

Stem cell factor (SCF) promotes blood cell growth and survival. New inhibitors of SCF signaling offer potential treatments for Kit+ cancers like acute myeloblastic leukemia.

Area of Science:

  • Hematology
  • Molecular Biology
  • Cancer Biology

Background:

  • Stem cell factor (SCF) is a crucial growth factor for hematopoietic progenitor cells.
  • SCF exhibits proliferative and anti-apoptotic functions, vital for blood cell development.
  • SCF signaling pathways are increasingly understood by molecular biologists.

Purpose of the Study:

  • To review recent advancements in Stem Cell Factor (SCF) signaling.
  • To explore the therapeutic potential of SCF pathway inhibitors in Kit+ malignancies.
  • To examine the synergistic roles of SCF in ex vivo cell expansion.

Main Methods:

  • Literature review of the past five years.
  • Analysis of molecular mechanisms of SCF signal transduction.
  • Collating data on SCF inhibitors and their clinical implications.

Related Experiment Videos

Main Results:

  • Dissection of SCF signaling pathways to the nucleus.
  • Availability of novel molecules that inhibit SCF signaling.
  • Demonstrated synergy of SCF with other cytokines for cell expansion.

Conclusions:

  • SCF pathway inhibition presents a promising therapeutic strategy for Kit+ malignancies, including acute myeloblastic leukemia.
  • Ex vivo expansion of hematopoietic progenitors and dendritic cells using SCF synergy holds therapeutic potential.
  • Recent research highlights SCF's multifaceted roles in hematopoiesis and cancer therapy.